Class action lawsuits have been filed against LKQ Corporation, Globant S.A., and SES AI Corporation, accusing them of making false or misleading statements and failing to disclose negative facts about their business operations and prospects. LKQ is alleged to have hidden issues related to FinishMaster and Uni-Select acquisitions affecting market share and financial performance. Globant reportedly failed to disclose declining demand and wage freezes in Latin America impacting its business. SES AI is accused of overstating business prospects, creating misleading revenue appearances, and facing logistics constraints affecting revenue guidance. Shareholders who suffered losses have until June 22-23, 2026, to file lead plaintiff motions to join the lawsuits. This development is important for investors considering legal recourse for potential losses due to alleged corporate misstatements.
Taco Bell Canada introduced two new menu items: Crispy Chicken Nuggets with a Jalapeño Honey Mustard sauce, and Mountain Dew Baja Midnight, the first new Mountain Dew Baja Blast flavor in over 20 years. The nuggets feature all-white meat with Mexican...
VERAXA Biotech updated on its progress in developing novel cancer therapies using its proprietary BiTAC platform, focusing on conditionally active T cell engagers and bispecific antibody-drug conjugates. The company plans to prioritize investment in ...
Nexans and Hydro have agreed on a five-year contract for about 85,000 tonnes of low-carbon aluminium wire rod to support Europe's electricity grid modernization. This aluminium, produced using 100% renewable energy in Norway, will help reduce carbon ...
Nexans and Hydro have agreed on a five-year supply contract for about 85,000 tons of low-carbon aluminum wire rod to support the modernization and decarbonization of Europe's electrical grid. The aluminum, produced in Norway using 100% renewable ener...
Scilex Holding Company announced a binding term sheet with Kazakhstan-based iHolding Group LLP for a $100 million investment, purchasing about 6.67 million shares at $15 each. This funding aims to support Scilex's strategic growth in healthcare, prod...
